Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-096841
Filing Date
2024-11-12
Accepted
2024-11-12 16:42:33
Documents
58
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0220290-10q_silopha.htm   iXBRL 10-Q 1103033
2 SECOND AMENDMENT TO EMPLOYMENT AGREEMENT DATED NOVEMBER 11, 2024 BETWEEN THE COM ea022029001ex10-3_silopharma.htm EX-10.3 12690
3 CERTIFICATION ea022029001ex31-1_silopharma.htm EX-31.1 13616
4 CERTIFICATION ea022029001ex31-2_silopharma.htm EX-31.2 13704
5 CERTIFICATION ea022029001ex32-1_silopharma.htm EX-32.1 5839
6 CERTIFICATION ea022029001ex32-2_silopharma.htm EX-32.2 5942
  Complete submission text file 0001213900-24-096841.txt   5561933

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE silo-20240930.xsd EX-101.SCH 51451
8 XBRL CALCULATION FILE silo-20240930_cal.xml EX-101.CAL 34241
9 XBRL DEFINITION FILE silo-20240930_def.xml EX-101.DEF 237028
10 XBRL LABEL FILE silo-20240930_lab.xml EX-101.LAB 483956
11 XBRL PRESENTATION FILE silo-20240930_pre.xml EX-101.PRE 243356
60 EXTRACTED XBRL INSTANCE DOCUMENT ea0220290-10q_silopha_htm.xml XML 560032
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41512 | Film No.: 241449215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)